Session 2: Importance of quality patient outcomes being at the center of universal health coverage programs

Photo Gallery

Session 2: "Importance of quality patient outcomes being at the center of universal health coverage programs" at MTaI MedTekon 2018
Session 2: "Importance of quality patient outcomes being at the center of universal health coverage programs" at MTaI MedTekon 2018
The session "Importance of quality patient outcomes being at the center of universal health coverage programs" was being chaired by Mr Ninad Gadgil, Country Business Leader, Healthcare, 3M India at MTaI MedTekon 2018
The session "Importance of quality patient outcomes being at the center of universal health coverage programs" was being chaired by Mr Ninad Gadgil, Country Business Leader, Healthcare, 3M India at MTaI MedTekon 2018
The session was moderated by Mr Prabal Chakraborty, VP & Managing Director, Boston Scientific India
The session was moderated by Mr Prabal Chakraborty, VP & Managing Director, Boston Scientific India
Dr Balram Bhargava, Director General, speaking on the perspective of patient access, quality assurance and outcome at MTaI MedTekon 2018
Dr Balram Bhargava, Director General, speaking on the perspective of patient access, quality assurance and outcome at MTaI MedTekon 2018
Mr Indu Bhushan, CEO, AB-NHPM & National Health Agency (NHA) sharing his views on importance of quality patient outcomes at MTaI MedTekon 2018
Mr Indu Bhushan, CEO, AB-NHPM & National Health Agency (NHA) sharing his views on importance of quality patient outcomes at MTaI MedTekon 2018
Dr V G Somani, Joint Drug Controller of India CDSCO sharing his view point at MTaI MedTekon 2018
Dr V G Somani, Joint Drug Controller of India CDSCO sharing his view point at MTaI MedTekon 2018
Dr Ratna Devi, CEO & Founder, DakshamA and Indian Alliance of Patients Group (IAPG) speaking during the session at MTaI MedTekon 2018
Dr Ratna Devi, CEO & Founder, DakshamA and Indian Alliance of Patients Group (IAPG) speaking during the session at MTaI MedTekon 2018
Dr Girdhar Gyani, Director General, AHPI speaking during the session on the importance of quality patient outcomes at MTaI MedTekon 2018
Dr Girdhar Gyani, Director General, AHPI speaking during the session on the importance of quality patient outcomes at MTaI MedTekon 2018
From left to right: Mr Nadeem Anam, MTaI, Mr Indu Bhushan, CEO, AB-NHPM & National Health Agency (NHA), Dr Balram Bhargava, Director General, ICMR, Dr V G Somani, Joint Drug Controller of India, CDSCO, Dr Girdhar Gyani, Director General, AHPI, Mr Ninad Gadgil, Country Business Leader, Healthcare, 3M India, Mr Prabal Chakraborty, VP & Managing Director, Boston Scientific India and Dr Ratna Devi, CEO & Founder, DakshamA and Indian Alliance of Patients Group (IAPG).
From left to right: Mr Nadeem Anam, MTaI, Mr Indu Bhushan, CEO, AB-NHPM & National Health Agency (NHA), Dr Balram Bhargava, Director General, ICMR, Dr V G Somani, Joint Drug Controller of India, CDSCO, Dr Girdhar Gyani, Director General, AHPI, Mr Ninad Gadgil, Country Business Leader, Healthcare, 3M India, Mr Prabal Chakraborty, VP & Managing Director, Boston Scientific India and Dr Ratna Devi, CEO & Founder, DakshamA and Indian Alliance of Patients Group (IAPG).